Rajesh Shinde
Vendite & Marketing presso ZOTA HEALTH CARE LIMITED
Profilo
Rajesh Shinde is currently working as the Manager-National Sales at Zota Health Care Ltd.
since 2016.
Prior to this, he worked as the Manager-National Sales at Astra IDL Ltd.
and as the Manager-Area Business at Emcure Pharmaceuticals Ltd.
Posizioni attive di Rajesh Shinde
| Società | Posizione | Inizio |
|---|---|---|
| ZOTA HEALTH CARE LIMITED | Vendite & Marketing | 12/01/2016 |
Precedenti posizioni note di Rajesh Shinde
| Società | Posizione | Fine |
|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | - |
| Astra IDL Ltd. | Vendite & Marketing | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ZOTA HEALTH CARE LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
| Astra IDL Ltd. | Health Technology |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Borsa valori
- Insiders
- Rajesh Shinde
